Custom gene ordering - Insights
With Mayo Clinic Laboratories’ custom gene ordering tool, clients can create specific gene panels to meet their patient’s individual needs.
At BioPharma Diagnostics, we are inspired by Mayo Clinic’s history of collaboration and breaking down barriers to change medicine. That’s why we bring Mayo Clinic expertise and quality to each project — from consulting through discovery to...
Demyelinating disease - Insights
Learn about our demyelinating disease testing, including multiple sclerosis, AQP4/MOG-associated disorders, and spinal cord disorders.
New tests launched in June - Insights
In June 2023, Mayo Clinic Laboratories announced 28 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in January - Insights
In January 2022, Mayo Clinic Laboratories announced twenty five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Embracing the transformative power of digital pathology - Insights
Mayo Clinic is harnessing the extraordinary potential of digital pathology through a robust initiative that’s using the technology to enhance patient care. Mayo’s Dermatology Department is an early adopter, and clinicians, students, and...
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
Cardiology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we know the importance of laboratory testing in a patient’s episode of care. Our unique combination of specialized laboratories and cardiology patient-care clinics allows us to reduce downstream costs with care-driven...
What's New in Health Care Reform: Feb. 6 - Insights
Top highlights include: New U.S. experiments aim to create gene-edited human embryos, death-cap mushrooms are spreading across North America, daily exercise has been shown to lower blood pressure, scans show female brains remain youthful as...
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...